18656-40-1

18656-40-1 - Names and Identifiers

Name	1,2-DILAUROYL-RAC-GLYCERO-3-PHOSPHOCHOLINE
Synonyms	DILAUROYL LECITHIN DL-BETA,GAMMA-DILAUROYL-ALPHA-LECITHIN DL-ALPHA-PHOSPHATIDYLCHOLINE, DILAUROYL 1,2-DILAUROYL-RAC-GLYCERO-3-PHOSPHOCHOLINE rac-1,2-dilauroyl-glycero-3-phospho-choline 1,2-DIDODECANOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE rac-1,2-Dilauroyl-glycero-3-phosphocholine, rac-Phosphatidylcholine, 1,2-dilauroyl, DL-α-Dilauroyl phosphatidylcholine, DL-β,γ-Dilauroyl-α-lecithin
CAS	18656-40-1
EINECS	242-482-7

18656-40-1 - Physico-chemical Properties

Molecular Formula	C32H64NO8P
Molar Mass	621.83
BRN	4168394
Storage Condition	−20°C

18656-40-1 - Risk and Safety

WGK Germany	3
FLUKA BRAND F CODES	10-21

18656-40-1 - Introduction

1, is also known as 1, and is a phospholipid molecule. Here are some information about its nature, use, formulation and safety:

Properties: 1, is a white solid, has good solubility, can be dissolved in water and organic solvents. It is a non-ionic surfactant with good emulsifying, thickening and dispersing effects.

Uses: 1. It is mainly used to prepare drug nano-delivery systems as drug carriers and auxiliary components. It can enhance the solubility and stability of the drug, improve the targeting and transport efficiency of the drug to the target, thereby improving the efficacy of the drug.

Preparation Method: 1, the preparation of the general use of organic synthesis methods. Specific steps include first synthesizing 1,2-didodecanoyl-RAC-glycerol and then reacting with 3-Choline phosphate to form the final product.

Safety information: Regarding the safety of 1, it has not been found that it has obvious toxicity or harm to the human body or the environment. However, it is still necessary to follow the safety regulations of general laboratory operations during use, such as wearing appropriate personal protective equipment and avoiding contact with skin, eyes or inhalation. It is best to conduct an adequate safety assessment before use and use in accordance with relevant regulations and guidelines.

Last Update：2024-04-09 21:32:50